Wednesday, August 20, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Karl Keirstead Bullish on GitLab with Buy Rating and Revised Price Target

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Biotechnology Stock Bull Market
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Karl Keirstead from UBS reiterates his bullish stance on GitLab (NASDAQ: GTLB) with a Buy rating, while revising the price target down to $75 from $81. Keirstead remains optimistic about the company’s future prospects and believes in its potential for growth.

GTLB Stock Plummets by 18.67% on March 5, 2024: What Investors Need to Know

On March 5, 2024, GTLB stock experienced a significant drop in price, with shares decreasing by $13.90 since the previous market close. This represents an 18.67% decrease in value, which is a significant decline for investors holding GTLB shares.

The stock opened at $59.95 on March 5, which was $14.52 lower than its previous close. This sharp drop in the opening price indicates that there was likely negative sentiment surrounding GTLB on that day, leading to a sell-off by investors.

Despite this drop in price, GTLB is still trading in the middle of its 52-week range and above its 200-day simple moving average. This suggests that while there was a significant decline on March 5, the stock’s overall performance has been relatively stable compared to its historical range.

GTLB Stock Analysis: Mixed Performances in Revenue, Net Income, and EPS

On March 5, 2024, GTLB stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $579.91 million for the past year, representing a 36.66% increase compared to the previous year. Additionally, the total revenue for the fourth quarter was $163.78 million, showing a 9.43% increase from the previous quarter.

GTLB reported a net income of -$424.17 million for the past year, which is a significant decrease of 146.17% compared to the previous year. On a positive note, the net income for the fourth quarter improved to -$36.47 million, representing an 87.21% increase from the previous quarter.

Earnings per share (EPS) also showed a mixed performance for GTLB stock. The EPS for the past year was -$2.75, indicating a 136.78% decrease compared to the previous year. Interestingly, the EPS for the fourth quarter remained unchanged at -$0.23 compared to the previous quarter.

Overall, the financial data suggests that GTLB stock has experienced both positive and negative performances in various aspects of its financials. Investors may want to closely monitor the company’s future earnings reports and financial updates to assess the stock’s performance and make informed investment decisions.

Tags: GTLB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ stocks to buy

UBS Analyst Maintains Neutral Rating on Ziff Davis Lowers Price Target to 76

Finance_ projections

Jonathan Painter Sells 23 Million Worth of Kadant Stock

Finance_Assets (2)

SunOpta Receives Buy Rating and Increased Price Target from Analysts

Recommended

EQR stock news

Significant Investment and Trading Activity at Stifel Financial Corp.: Increased Stake by Victory Capital Management Inc. and Selling Transactions by SVP Thomas B. Michaud

2 years ago
Automating Financial Advisory Services: The Rise of End-to-End Solutions for RIAs

Analyzing Analyst Views on Snowflake NYSE SNOW

1 year ago
Finance_ Stock Charts (2)

Kaival Brands Innovations Group Implements GameChanging Reverse Stock Split to Drive Growth and Compliance

2 years ago
Healthcare-and-IT

Grifols Focuses on Deleveraging Strategy for Enhanced Financial Performance

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NIO NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Peloton’s Contradictory Signals: Insiders Sell as Institutions Buy

Viking Therapeutics Shares Plunge on Clinical Trial Safety Concerns

Broadcom Leadership Sells Holdings Amid AI-Driven Stock Surge

A Hidden Force in the AI Semiconductor Surge

The AI Arms Race: Microsoft and Alphabet’s Divergent Paths to Dominance

Key Engineer’s Departure from Altair Signals China’s Tech Ambitions

Trending

West Pharmaceutical Stock
Stocks

West Pharmaceutical Shares Defy Technical Warnings with Strong Quarterly Surge

by Robert Sasse
August 20, 2025
0

A fascinating divergence is playing out in West Pharmaceutical's stock performance. Despite technical indicators flashing warning signs...

SK TelecomADR Stock

Can AI Growth Offset Core Weakness at SK Telecom?

August 20, 2025
CSX Stock

Activist Investor Ramps Up Pressure on CSX Board Amid Rail Industry Shakeup

August 20, 2025
Peloton Stock

Peloton’s Contradictory Signals: Insiders Sell as Institutions Buy

August 20, 2025
Viking Therapeutics Stock

Viking Therapeutics Shares Plunge on Clinical Trial Safety Concerns

August 20, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • West Pharmaceutical Shares Defy Technical Warnings with Strong Quarterly Surge August 20, 2025
  • Can AI Growth Offset Core Weakness at SK Telecom? August 20, 2025
  • Activist Investor Ramps Up Pressure on CSX Board Amid Rail Industry Shakeup August 20, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com